Bannister Law, which recently launched a class action in the Federal Court of Australia against Reckitt Benckiser (Australia), makers of Nurofen, says the Nurofen class action was settled on July 31, 2017, for $3.5 million plus the applicants’ legal costs.
Under the terms of the settlement deed, the respondent or Reckitt Benckiser will pay the sum of $3.5 million into a settlement fund for distribution to eligible group members. This fund will be administered by an independent third party during a period of four months.
Bannister Law says it anticipates settlement notices will soon be published in newspapers in every Australian state, calling for consumers who bought the Nurofen Specific Pain Range products between 2011 and 2015 to come forward and register their claim for compensation from the settlement fund.
A further update will be provided once Bannister Law knows more about the settlement timetable. In the meantime, it urges all individuals who believe they have a claim to register their particulars by visiting http://nurofenclassaction.com.au/